Forte Biosciences (FBRX) Competitors $13.81 -0.03 (-0.22%) Closing price 07/3/2025 03:25 PM EasternExtended Trading$13.02 -0.80 (-5.76%) As of 07/3/2025 04:40 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock FBRX vs. BNTC, ITOS, RVNC, ABVX, FULC, SLDB, CKPT, TECX, VIGL, and ETONShould you be buying Forte Biosciences stock or one of its competitors? The main competitors of Forte Biosciences include Benitec Biopharma (BNTC), iTeos Therapeutics (ITOS), Revance Therapeutics (RVNC), Abivax (ABVX), Fulcrum Therapeutics (FULC), Solid Biosciences (SLDB), Checkpoint Therapeutics (CKPT), Tectonic Therapeutic (TECX), Vigil Neuroscience (VIGL), and Eton Pharmaceuticals (ETON). These companies are all part of the "pharmaceutical products" industry. Forte Biosciences vs. Its Competitors Benitec Biopharma iTeos Therapeutics Revance Therapeutics Abivax Fulcrum Therapeutics Solid Biosciences Checkpoint Therapeutics Tectonic Therapeutic Vigil Neuroscience Eton Pharmaceuticals Benitec Biopharma (NASDAQ:BNTC) and Forte Biosciences (NASDAQ:FBRX) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, valuation, media sentiment, dividends, analyst recommendations, institutional ownership and profitability. Do analysts rate BNTC or FBRX? Benitec Biopharma currently has a consensus target price of $23.83, suggesting a potential upside of 81.38%. Forte Biosciences has a consensus target price of $61.00, suggesting a potential upside of 341.71%. Given Forte Biosciences' higher possible upside, analysts plainly believe Forte Biosciences is more favorable than Benitec Biopharma.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Benitec Biopharma 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 2 Strong Buy rating(s) 3.22Forte Biosciences 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is BNTC or FBRX more profitable? Benitec Biopharma's return on equity of -38.26% beat Forte Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets Benitec BiopharmaN/A -38.26% -35.71% Forte Biosciences N/A -149.15%-114.25% Does the media prefer BNTC or FBRX? In the previous week, Benitec Biopharma had 1 more articles in the media than Forte Biosciences. MarketBeat recorded 1 mentions for Benitec Biopharma and 0 mentions for Forte Biosciences. Benitec Biopharma's average media sentiment score of 0.00 equaled Forte Biosciences'average media sentiment score. Company Overall Sentiment Benitec Biopharma Neutral Forte Biosciences Neutral Which has better valuation and earnings, BNTC or FBRX? Benitec Biopharma has higher revenue and earnings than Forte Biosciences. Benitec Biopharma is trading at a lower price-to-earnings ratio than Forte Biosciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBenitec Biopharma$80K4,311.56-$21.75M-$1.51-8.70Forte BiosciencesN/AN/A-$35.48M-$16.29-0.85 Do institutionals & insiders have more ownership in BNTC or FBRX? 52.2% of Benitec Biopharma shares are held by institutional investors. Comparatively, 77.6% of Forte Biosciences shares are held by institutional investors. 1.3% of Benitec Biopharma shares are held by company insiders. Comparatively, 5.9% of Forte Biosciences shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Which has more volatility and risk, BNTC or FBRX? Benitec Biopharma has a beta of 0.37, indicating that its stock price is 63% less volatile than the S&P 500. Comparatively, Forte Biosciences has a beta of 2.97, indicating that its stock price is 197% more volatile than the S&P 500. SummaryBenitec Biopharma beats Forte Biosciences on 9 of the 14 factors compared between the two stocks. Get Forte Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for FBRX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding FBRX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FBRX vs. The Competition Export to ExcelMetricForte BiosciencesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$89.93M$2.91B$5.53B$9.05BDividend YieldN/A2.44%5.24%4.03%P/E Ratio-0.8521.5627.5220.22Price / SalesN/A281.76421.02118.64Price / CashN/A42.7336.8958.07Price / Book1.687.518.045.67Net Income-$35.48M-$55.05M$3.18B$249.13M7 Day Performance12.73%4.61%2.90%3.28%1 Month Performance33.43%4.72%3.70%5.55%1 Year PerformanceN/A5.92%36.15%21.12% Forte Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FBRXForte Biosciences2.5698 of 5 stars$13.81-0.2%$61.00+341.7%+67,596.1%$89.93MN/A-0.855BNTCBenitec Biopharma1.6103 of 5 stars$14.57-0.3%$23.83+63.6%+48.6%$383.52M$80K-9.6520High Trading VolumeITOSiTeos Therapeutics3.2084 of 5 stars$10.11+1.5%$15.86+56.8%-31.2%$381.21M$35M-3.3390RVNCRevance Therapeutics2.7795 of 5 stars$3.65flat$8.45+131.5%N/A$381.02M$234.04M-1.89500ABVXAbivax2.4223 of 5 stars$6.11+2.3%$31.00+407.4%-39.0%$378.82MN/A0.0061News CoveragePositive NewsGap UpFULCFulcrum Therapeutics0.3305 of 5 stars$7.17+2.6%$6.29-12.3%+13.8%$377.58M$80M-102.41100SLDBSolid Biosciences3.3055 of 5 stars$4.51-5.8%$14.90+230.4%-16.6%$371.30M$8.09M-1.51100Gap UpCKPTCheckpoint Therapeutics0.4915 of 5 stars$4.26flat$4.33+1.7%N/A$370.71M$41K-2.3210TECXTectonic Therapeutic3.6137 of 5 stars$18.75-5.4%$82.33+339.1%+38.6%$369.90MN/A-2.56120Analyst UpgradeVIGLVigil Neuroscience3.3566 of 5 stars$7.94+0.3%$10.80+36.0%+102.3%$369.64MN/A-3.8740ETONEton Pharmaceuticals2.5099 of 5 stars$13.51-0.4%$29.67+119.6%+341.5%$363.91M$39.01M-75.0620 Related Companies and Tools Related Companies BNTC Competitors ITOS Competitors RVNC Competitors ABVX Competitors FULC Competitors SLDB Competitors CKPT Competitors TECX Competitors VIGL Competitors ETON Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:FBRX) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredA grave, grave error.Famed financial analyst, Porter Stansberry, calls this technology “The Final Frontier” because it holds the ke...Porter & Company | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Forte Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Forte Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free FBRX Stock Alerts